K27/G34 versus K28/G35 in histone H3-mutant gliomas: A note of caution

This is a preview of subscription content, log in to check access.

Fig. 1

References

  1. 1.

    Bechet D, Gielen GG, Korshunov A, Pfister SM, Rousso C, Faury D, Fiset PO, Benlimane N, Lewis PW, Lu C et al (2014) Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas. Acta Neuropathol 128:733–741. https://doi.org/10.1007/s00401-014-1337-4

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. 2.

    Castel D, Philippe C, Calmon R, Le Dret L, Truffaux N, Boddaert N, Pages M, Taylor KR, Saulnier P, Lacroix L et al (2015) Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes. Acta Neuropathol 130:815–827. https://doi.org/10.1007/s00401-015-1478-0

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. 3.

    Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W et al (2002) Mutations of the BRAF gene in human cancer. Nature 417:949–954. https://doi.org/10.1038/nature00766

    Article  PubMed  CAS  Google Scholar 

  4. 4.

    Iwai K, Ishikawa K, Hayashi H (1970) Amino-acid sequence of slightly lysine-rich histone. Nature 226:1056–1058

    Article  PubMed  CAS  Google Scholar 

  5. 5.

    Jansen MH, Veldhuijzen van Zanten SE, Sanchez Aliaga E, Heymans MW, Warmuth-Metz M, Hargrave D, van der Hoeven EJ, Gidding CE, de Bont ES, Eshghi OS et al (2015) Survival prediction model of children with diffuse intrinsic pontine glioma based on clinical and radiological criteria. Neuro Oncol 17:160–166. https://doi.org/10.1093/neuonc/nou104

    Article  PubMed  Google Scholar 

  6. 6.

    Johnson A, Severson E, Gay L, Vergilio JA, Elvin J, Suh J, Daniel S, Covert M, Frampton GM, Hsu S et al (2017) Comprehensive genomic profiling of 282 pediatric low- and high-grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures. Oncologist 22:1478–1490. https://doi.org/10.1634/theoncologist.2017-0242

    Article  PubMed  CAS  Google Scholar 

  7. 7.

    Louis DN, Giannini C, Capper D, Paulus W, Figarella-Branger D, Lopes MB, Batchelor TT, Cairncross JG, van den Bent M, Wick W et al (2018) cIMPACT-NOW update 2: diagnostic clarifications for diffuse midline glioma, H3 K27M-mutant and diffuse astrocytoma/anaplastic astrocytoma, IDH-mutant. Acta Neuropathol. https://doi.org/10.1007/s00401-018-1826-y

    Article  PubMed  Google Scholar 

  8. 8.

    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1

    Article  PubMed  Google Scholar 

  9. 9.

    Mohammad F, Weissmann S, Leblanc B, Pandey DP, Hojfeldt JW, Comet I, Zheng C, Johansen JV, Rapin N, Porse BT et al (2017) EZH2 is a potential therapeutic target for H3K27M-mutant pediatric gliomas. Nat Med 23:483–492. https://doi.org/10.1038/nm.4293

    Article  PubMed  CAS  Google Scholar 

  10. 10.

    Ogino S, Gulley ML, den Dunnen JT, Wilson RB, Association for Molecular Patholpogy T, Education C (2007) Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. J Mol Diagn 9:1–6. https://doi.org/10.2353/jmoldx.2007.060081

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. 11.

    Schwartzentruber J, Korshunov A, Liu XY, Jones DT, Pfaff E, Jacob K, Sturm D, Fontebasso AM, Quang DA, Tonjes M et al (2012) Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 482:226–231. https://doi.org/10.1038/nature10833

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Henning Leske.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Leske, H., Rushing, E., Budka, H. et al. K27/G34 versus K28/G35 in histone H3-mutant gliomas: A note of caution. Acta Neuropathol 136, 175–176 (2018). https://doi.org/10.1007/s00401-018-1867-2

Download citation